Literature DB >> 10856979

Fibrinolysis and thrombosis.

N A Booth1.   

Abstract

The fibrinolytic system generates plasmin, which dissolves fibrin in haemostatic plugs and in thrombi. It is often regarded simply as a secondary phenomenon responsive to the generation of thrombi but it is, rather, in dynamic balance with fibrin formation, such that abnormalities in either can lead to thrombosis. This chapter summarizes the fibrinolytic system and its regulation. It considers the components of the system in blood, both in plasma and in circulating cells, with emphasis on protease-inhibitor balance. It goes on to discuss local fibrinolytic potential in thrombi, both venous and arterial, and in the diseased vessel wall, presenting evidence that increased local inhibition of fibrinolysis by PAI-1, PAI-2 and alpha2-antiplasmin is intimately involved in thrombus stability and in the generation of fibrin-rich vessel wall lesions. Finally, it reviews the evidence that defective plasma fibrinolysis has a causal role in venous and arterial thrombosis.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10856979     DOI: 10.1053/beha.1999.0034

Source DB:  PubMed          Journal:  Baillieres Best Pract Res Clin Haematol


  16 in total

1.  Identification of polyclonal and monoclonal antibodies against tissue plasminogen activator in the antiphospholipid syndrome.

Authors:  Cai-Sheng Lu; Arash A Horizon; Kwan-Ki Hwang; John FitzGerald; Wei-Shiang Lin; Bevra H Hahn; Daniel J Wallace; Allan L Metzger; Michael H Weisman; Pojen P Chen
Journal:  Arthritis Rheum       Date:  2005-12

Review 2.  Plasminogen activator inhibitor-1 and thrombotic cerebrovascular diseases.

Authors:  Anna Tjärnlund-Wolf; Helen Brogren; Eng H Lo; Xiaoying Wang
Journal:  Stroke       Date:  2012-08-09       Impact factor: 7.914

3.  Increase in post-reperfusion sensitivity to tissue plasminogen activator-mediated fibrinolysis during liver transplantation is associated with abnormal metabolic changes and increased blood product utilisation.

Authors:  Hunter B Moore; Angelo D'Alessandro; Ernest E Moore; Matthew Wither; Peter J Lawson; Benjamin R Huebner; Kirk Hansen; Rashikh Choudhury; Trevor L Nydam
Journal:  Blood Transfus       Date:  2019-02-04       Impact factor: 3.443

4.  Tissue plasminogen activator antigen predicts medium-term left ventricular end-systolic volume after acute myocardial infarction.

Authors:  Robin A P Weir; Sean Balmain; Tracey Steedman; Leong L Ng; Iain B Squire; Anne Rumley; Henry J Dargie; Gordon D O Lowe
Journal:  J Thromb Thrombolysis       Date:  2010-05       Impact factor: 2.300

5.  Shock-induced systemic hyperfibrinolysis is attenuated by plasma-first resuscitation.

Authors:  Hunter B Moore; Ernest E Moore; Alexander P Morton; Eduardo Gonzalez; Miguel Fragoso; Michael P Chapman; Monika Dzieciatkowska; Kirk C Hansen; Anirban Banerjee; Angela Sauaia; Christopher C Silliman
Journal:  J Trauma Acute Care Surg       Date:  2015-12       Impact factor: 3.313

Review 6.  Extracellular matrix and matrix receptors in blood-brain barrier formation and stroke.

Authors:  Kim M Baeten; Katerina Akassoglou
Journal:  Dev Neurobiol       Date:  2011-11       Impact factor: 3.964

7.  Viscoelastic measurements of platelet function, not fibrinogen function, predicts sensitivity to tissue-type plasminogen activator in trauma patients.

Authors:  H B Moore; E E Moore; M P Chapman; E Gonzalez; A L Slaughter; A P Morton; A D'Alessandro; K C Hansen; A Sauaia; A Banerjee; C C Silliman
Journal:  J Thromb Haemost       Date:  2015-09-22       Impact factor: 5.824

8.  Biochemical mechanism of action of a diketopiperazine inactivator of plasminogen activator inhibitor-1.

Authors:  Anja P Einholm; Katrine E Pedersen; Troels Wind; Paulina Kulig; Michael T Overgaard; Jan K Jensen; Julie S Bødker; Anni Christensen; Peter Charlton; Peter A Andreasen
Journal:  Biochem J       Date:  2003-08-01       Impact factor: 3.857

9.  Fibrinolysis shutdown is associated with a fivefold increase in mortality in trauma patients lacking hypersensitivity to tissue plasminogen activator.

Authors:  Hunter B Moore; Ernest E Moore; Benjamin R Huebner; Monika Dzieciatkowska; Gregory R Stettler; Geoffrey R Nunns; Peter J Lawson; Arsen Ghasabyan; James Chandler; Anirban Banerjee; Christopher Silliman; Angela Sauaia; Kirk C Hansen
Journal:  J Trauma Acute Care Surg       Date:  2017-12       Impact factor: 3.313

10.  Acute coronary syndromes: from the laboratory markers to the coronary vessels.

Authors:  Palazzuoli Alberto; Iovine Francesca; Scali Chiara; Nuti Ranuccio
Journal:  Biomark Insights       Date:  2007-02-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.